Get App

UK adds nerve disorder as rare side-effect of AstraZeneca COVID-19 vaccine

Medicines and Healthcare products Regulatory Agency's (MHRA) decision comes after the European medicines agency added GBS as a possible side-effect last month.
  • Published On Oct 21, 2021 at 06:24 PM IST
Read by: 100 Industry Professionals
Reader Image Read by 100 Industry Professionals
The UK drug regulator added an extremely rare nerve-damaging disorder, Guillain-Barre syndrome (GBS), as a very rare side effect of the AstraZeneca COVID-19 vaccine, updates on the agency's website showed on Thursday.

Medicines and Healthcare products Regulatory Agency's (MHRA) decision comes after the European medicines agency added GBS as a possible side-effect last month.


  • Published On Oct 21, 2021 at 06:24 PM IST
Be the first one to comment.
Comment Now

COMMENTS

Comment Now Read Comment (1)

Join the community of 2M+ industry professionals

Subscribe to our newsletter to get latest insights & analysis.

Download ETHealthworld App

  • Get Realtime updates
  • Save your favourite articles
Scan to download App